The drug delivery space has seen plenty of innovation over the years and there are no signs of that slowing down any time soon. Improvements upon established technologies like insulin delivery devices and inhalers have been presented by some, while others have unlocked new ways of delivering drugs through a variety of means. Among the […]
Technology
Phillips-Medisize, Subcuject team on wearable osmotic bolus injector
Phillips-Medisize announced today that it is collaborating with Subcuject to bring a wearable bolus injector to market. Hudson, Wis.-based Phillips-Medisize, a Molex company, said in a news release that the on-body delivery system technology that is based on osmosis is now available for the next stage of drug-specific wearable injector solution after Subcuject filed for […]
Amazon, Onica to support digital health for Teva’s Digihaler
Teva Respiratory (NYSE:TEVA) announced that it is collaborating with Amazon Web Services (AWS) and Onica to build and host its digital health platform. The Teva Pharmaceuticals affiliate’s digital health platform is a cloud-based backend data system designed to support its FDA-approved Digihaler portfolio of breath-actuated digital inhalers and its companion mobile app that tracks inhaler events […]
Nemaura Medical repurposes its CGM to spot coronavirus fevers
Nemaura Medical (NSDQ:NMRD) announced today that it is planning to immediately repurpose its SugarBeat continuous glucose monitor (CGM) as a continuous temperature monitor (CTM) to help diagnose fevers in potential cases of COVID-19. The Loughborough, England-based company said in a news release that its inbuilt temperature sensor is capable of continuously tracking body temperature through the […]
7 medtech advances to improve diabetes treatment
Medtech and pharmaceutical companies have made several important strides over the past year when it comes to improving diabetes treatment. Multiple treatments and technologies have cleared regulatory hurdles and are now hitting the market and making the process of living with diabetes that much more manageable. Several different styles of therapy and devices have come […]
Ambrosia app links Abbott’s FreeStyle Libre with Fitbit wearable
Ambrosia Systems said today that it launched its LinkBlueCon application on the Fitbit and Abbott (NYSE:ABT) FreeStyle Libre smartwatch platforms for glucose monitoring. San Fransisco-based Ambrosia’s LinkBlueCon app is designed to monitor glucose levels and receive notifications when glucose readings are outside the target range, all without the need to go to a clinic. Ambrosia said […]
How Covestro polycarbonate is enabling syringe innovation
Covestro officials are boasting how their Apec 1745 high heat polycarbonate was the material of choice for Gerresheimer AG’s new tamper-evident luer lock closure for syringes. In the growing prefilled syringes market, the adapter for screwing in the needle and the syringe cap plays a key role when it comes to ensuring ease of use and reliable dosage, […]
Teva launches generic EpiPen at the same price as existing device
Teva (NYSE:TEVA) this week launched its generic version of Mylan‘s (NSDQ:MYL) EpiPen auto-injector and announced that it would sell the emergency allergy therapy for $300 – the same price as Mylan’s own generic EpiPen product. The price for Teva’s product inspired some head-scratching among patient advocates and healthcare professionals. After all, when the FDA first approved […]
New diabetes software from Klue features mealtime insulin reminders
Digital health company Klue announced this week that its latest AI-driven software is a module designed for people with Type I diabetes. The technology features autonomous meal detection capabilities and provides mealtime medication reminders to users, according to the San Francisco, Calif.-based company. The module, which works with hardware like the Apple Watch, also provides […]
Abbott CEO on Libre: ‘We’re just getting started’
Abbott (NYSE:ABT) posted its third quarter financial results yesterday, meeting its own forecast and the consensus set by analysts on Wall Street. The healthcare giant also narrowed its earnings outlook for the rest of the year. Abbott noted particularly high gains in revenue for its medical device division – sales were up 8.4% to $2.82 billion, in […]
